Clinical Trial Update: A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea

View source ↗

Summary

This update outlines a clinical trial evaluating Fruzaqla for metastatic colorectal cancer in adults in South Korea, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FRUZAQLA (fruquintinib)

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Status: RECRUITING